Transcatheter left atrial appendage closure for stroke prevention among atrial fibrillation patients

References

• Mant J, Hobbs FD, Fletcher K et al.; BAFTA investigators; Midland Research Practices Network (MidReC). Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 370(9586), 493–503 (2007).
   PubMed Web of Science ®Google Scholar
• van Walraven C, Hart RG, Connolly S et al. Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators. Stroke 40(4), 1410–1416 (2009).
   PubMed Web of Science ®Google Scholar
• Granger CB, Armaganijan LV. Newer oral anticoagulants should be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation and risk factors for stroke or thromboembolism. Circulation 125(1), 159–64; discussion 164 (2012).
   PubMed Web of Science ®Google Scholar
• Nieuwlaat R, Capucci A, Camm AJ et al.; European Heart Survey Investigators. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur. Heart J. 26(22), 2422–2434 (2005).
   PubMed Web of Science ®Google Scholar
• Birman-Deych E, Radford MJ, Nilasena DS, Gage BF. Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation. Stroke 37(4), 1070–1074 (2006).
   PubMed Web of Science ®Google Scholar
• Manning WJ, Weintraub RM, Waksmonski CA et al. Accuracy of transesophageal echocardiography for identifying left atrial thrombi: a prospective, intraoperative study. Ann. Intern. Med. 123(11), 817–822 (1995).
   PubMed Web of Science ®Google Scholar
• Tsai LM, Chen JH, Lin LJ, Yang YJ. Role of transesophageal echocardiography in detecting left atrial thrombus and spontaneous echo contrast in patients with mitral valve disease or non-rheumatic atrial fibrillation. J. Formos. Med. Assoc. 89(4), 270–274 (1990).
   Google Scholar
• Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann. Thorac. Surg. 61(2), 755–759 (1996).
   PubMed Web of Science ®Google Scholar
• Bonow RO, Carabello BA, Chatterjee K et al.; ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J. Am. Coll. Cardiol. 48(3), e1–e148 (2006).
   Google Scholar
• Blackshear JL, Johnson WD, Odell JA et al. Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation. J. Am. Coll. Cardiol. 42(7), 1249–1252 (2003).
   Google Scholar
• Sievert H, Lesh MD, Trepels T et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience. Circulation 105(16), 1887–1889 (2002).
   PubMed Web of Science ®Google Scholar
• Ostermayer SH, Reisman M, Kramer PH et al. Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. J. Am. Coll. Cardiol. 46(1), 9–14 (2005).
   PubMed Web of Science ®Google Scholar
• Meier B, Palacios I, Windecker S et al. Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation. Catheter. Cardiovasc. Interv. 60(3), 417–422 (2003).
   PubMed Web of Science ®Google Scholar
• Sick PB, Schuler G, Hauptmann KE et al. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. J. Am. Coll. Cardiol. 49(13), 1490–1495 (2007).
   PubMed Web of Science ®Google Scholar
• Holmes DR, Reddy VY, Turi ZG et al.; PROTECT AF Investigators. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 374(9689), 534–542 (2009).
   PubMed Web of Science ®Google Scholar
• Toumanides S, Sideris EB, Agricola T, Moulopoulos S. Transcatheter patch occlusion of the left atrial appendage using surgical adhesives in high-risk patients with atrial fibrillation. J. Am. Coll. Cardiol. 58(21), 2236–2240 (2011).
   Web of Science ®Google Scholar
• Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation 123(4), 417–424 (2011).
   PubMed Web of Science ®Google Scholar
• Viles-Gonzalez JF, Reddy VY, Petru J et al. Incomplete occlusion of the left atrial appendage with the percutaneous left atrial appendage transcatheter occlusion device is not associated with increased risk of stroke. J. Interv. Card. Electrophysiol. 33(1), 69–75 (2012).
   Google Scholar
• Bartus K, Bednarek J, Myc J et al. Feasibility of closed-chest ligation of the left atrial appendage in humans. Heart Rhythm 8(2), 188–193 (2011).
   Web of Science ®Google Scholar